FDA approves life-extending pancreatic cancer drug Rasonque
The Food and Drug Administration approved Revolution Medicines' promising pancreatic cancer drug on Aug. 26 after a clinical trial showed life expectancy nearly doubled for patients with disease that had spread to other parts of the body. The drug, …